Overview
What is CA 19.9; PANCREATIC CANCER MARKER ?
CA19.9 is a protein in the blood which is usually increased in patients suffering from pancreatic cancer. This test is used to monitor the status of pancreatic cancer during & after treatment. It is also used as a marker to look for early signs of recurrence. It should not be used as a screening test for the population because many other conditions also increase the CA19.9 levels in blood.

- CA 19.9 PANCREATIC CANCER MARKER, SERUM
Doctor Information
Pre-test Information
Provide brief clinical history.
Report Delivery
Next day Evening Except Sunday
Category
Cancer
Stability Room
8 hrs
Stability Refrigerated
1 week
Stability Frozen
2 weeks
Method
Chemiluminesc
ence Immunoassay (CLIA)/ELISA
Specimen
2 ml. (1 ml. Minimum) Serum
Usage
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.